comparemela.com
Latest Breaking News On - Tisagenlecleucel - Page 1 : comparemela.com
NICE Recommends Tisagenlecleucel for Pediatric R/R B-ALL
The National Institute for Health and Care Excellence has recommended the use of tisagenlecleucel in pediatric B-cell acute lymphoblastic leukemia.
United-kingdom
Helen-knight
National-health-service
Cancer-drugs-fund
United-kingdom-national-institute-for-health
National-institute-for-health-care-excellence
National-institute
Care-excellence
Health-care
Pediatricb-cell-acute-lymphoblastic-leukemia
National-institute-for-health-and-care-excellence
Tisagenlecleucel
CAR T-cells as Third-line and Beyond Therapy for FL
Bijal Shah, MD, discusses recent data on CAR T-cell therapy as third-line and beyond treatment for FL.
Bijal-shah
Recent-updates
Follicular-lymphoma
Mantle-cell-lymphoma
Beyond-therapy
Fl
Cmcl
Cart-cell-therapy
Bendamustine
Zuma-5
Axicabtagene-ciloleucel
Tisagenlecleucel Yields Durable Responses in R/R Follicular Lymphoma
Patients with relapsed/refractory follicular lymphoma experienced durable responses when treated with tisagenlecleucel (Kymriah) in the phase 2 ELARA study (NCT03568461), according to data presented at the 2023 ASH Annual Meeting.
Stephenj-schuster
Margarita-louis-dreyfus-professor
Chronic-lymphocytic-leukemia
Lymphoma-clinical-care
Cash
Tisagenlecleucel
Follicular-lymphoma
Elara-study
Relapsed-refractory-follicular-lymphoma
Kymriah
Study Examines Axi-Cel Use for Follicular Lymphoma Management
Researchers compared chimeric antigen receptor T-cell therapies axicabtagene ciloleucel (axi-cel) and tisagenlecleucel.
Cancer-management
Axicabtagene-ciloleucel
Axi-cel
Tisagenlecleucel
Follicular-lymphoma
Cd3zeta-
Zuma-5
Car-t
vimarsana © 2020. All Rights Reserved.